Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Plos One
|
July 19, 2012
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target
Ulises D Orlando, Juan Garona, Giselle V Ripoll, et al.
Frontiers in Cell and Developmental Biology
|
May 1, 2020
Computational and <i>in vitro</i> Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity
Nazareno González, Georgina A Cardama, Patricio Chinestrad, et al.
Journal of Pain Research
|
November 9, 2023
The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices
Timothy Sowder, Dawood Sayed, Tyler Concannon, et al.
Carcinogenesis
|
May 29, 2004
Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice
Masaharu Yamazaki, Takemi Akahane, Todd Buck, et al.
International Journal of Oncology
|
April 8, 2015
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
Juan Garona, Marina Pifano, Ulises D Orlando, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 13, 2012
Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization
Yasser Perera, Heydi C Costales, Yakelin Diaz, et al.
Cancers
|
October 14, 2022
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
Georgina A Cardama, Julian Maggio, Lucas Valdez Capuccino, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 17, 2020
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis
Ana F Castillo, Ulises D Orlando, Paula M Maloberti, et al.
Springerplus
|
August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Plos One
|
July 19, 2012
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 controls tumor growth: a novel therapeutic target
Ulises D Orlando, Juan Garona, Giselle V Ripoll, et al.
Frontiers in Cell and Developmental Biology
|
May 1, 2020
Computational and <i>in vitro</i> Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity
Nazareno González, Georgina A Cardama, Patricio Chinestrad, et al.
Journal of Pain Research
|
November 9, 2023
The American Society of Pain and Neuroscience (ASPN) Guidelines for Radiofrequency Ablative Procedures in Patients with Implanted Devices
Timothy Sowder, Dawood Sayed, Tyler Concannon, et al.
Carcinogenesis
|
May 29, 2004
Long-term exposure to elevated levels of circulating TIMP-1 but not mammary TIMP-1 suppresses growth of mammary carcinomas in transgenic mice
Masaharu Yamazaki, Takemi Akahane, Todd Buck, et al.
International Journal of Oncology
|
April 8, 2015
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models
Juan Garona, Marina Pifano, Ulises D Orlando, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 13, 2012
Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization
Yasser Perera, Heydi C Costales, Yakelin Diaz, et al.
Cancers
|
October 14, 2022
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
Georgina A Cardama, Julian Maggio, Lucas Valdez Capuccino, et al.
Cellular and Molecular Life Sciences : CMLS
|
October 17, 2020
New inhibitor targeting Acyl-CoA synthetase 4 reduces breast and prostate tumor growth, therapeutic resistance and steroidogenesis
Ana F Castillo, Ulises D Orlando, Paula M Maloberti, et al.
Springerplus
|
August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients
Ruth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.
Page
of 5